Related Articles by Review for PMID: 31369221

Year	Number of Results
2006	4
2012	1
2013	1
2015	2
2016	2
2017	2
2018	2
2019	2
2020	1
2021	2
2022	2
2023	1
2024	1
2025	1

1

[No authors listed] [No authors listed] 2025 Feb 15. Drugs and Lactation Database (LactMed®) [Internet]. Bethesda (MD): National Institute of Child Health and Human Development; 2006–. 2025 Feb 15. Drugs and Lactation Database (LactMed®) [Internet]. Bethesda (MD): National Institute of Child Health and Human Development; 2006–. PMID: 31369221 Free Books & Documents. Review.

2

Current Development and Challenges of Tetravalent Live-Attenuated Dengue Vaccines.

Hou J, Ye W, Chen J. Hou J, et al. Front Immunol. 2022 Feb 24;13:840104. doi: 10.3389/fimmu.2022.840104. eCollection 2022. Front Immunol. 2022. PMID: 35281026 Free PMC article. Review.

3

Historical discourse on the development of the live attenuated tetravalent dengue vaccine candidate TV003/TV005.

Durbin AP. Durbin AP. Curr Opin Virol. 2020 Aug;43:79-87. doi: 10.1016/j.coviro.2020.09.005. Epub 2020 Oct 23. Curr Opin Virol. 2020. PMID: 33164790 Free PMC article. Review.

4

Dengue vaccine: an update.

Huang CH, Tsai YT, Wang SF, Wang WH, Chen YH. Huang CH, et al. Expert Rev Anti Infect Ther. 2021 Dec;19(12):1495-1502. doi: 10.1080/14787210.2021.1949983. Epub 2021 Jul 13. Expert Rev Anti Infect Ther. 2021. PMID: 34182875 Review.

5

Clinical evaluation strategies for a live attenuated tetravalent dengue vaccine.

Precioso AR, Palacios R, Thomé B, Mondini G, Braga P, Kalil J. Precioso AR, et al. Vaccine. 2015 Dec 10;33(50):7121-5. doi: 10.1016/j.vaccine.2015.09.105. Epub 2015 Oct 14. Vaccine. 2015. PMID: 26458796 Review.

6

Dengvaxia: the world's first vaccine for prevention of secondary dengue.

Tully D, Griffiths CL. Tully D, et al. Ther Adv Vaccines Immunother. 2021 May 17;9:25151355211015839. doi: 10.1177/25151355211015839. eCollection 2021. Ther Adv Vaccines Immunother. 2021. PMID: 34036241 Free PMC article. Review.

7

Does structurally-mature dengue virion matter in vaccine preparation in post-Dengvaxia era?

Galula JU, Salem GM, Chang GJ, Chao DY. Galula JU, et al. Hum Vaccin Immunother. 2019;15(10):2328-2336. doi: 10.1080/21645515.2019.1643676. Epub 2019 Aug 23. Hum Vaccin Immunother. 2019. PMID: 31314657 Free PMC article. Review.

8

A recombinant live attenuated tetravalent vaccine for the prevention of dengue.

Guy B, Noriega F, Ochiai RL, L'azou M, Delore V, Skipetrova A, Verdier F, Coudeville L, Savarino S, Jackson N. Guy B, et al. Expert Rev Vaccines. 2017 Jul;16(7):1-13. doi: 10.1080/14760584.2017.1335201. Epub 2017 Jun 7. Expert Rev Vaccines. 2017. PMID: 28590795 Free article. Review.

9

Using recombinant DNA technology for the development of live-attenuated dengue vaccines.

Lee HC, Butler M, Wu SC. Lee HC, et al. Enzyme Microb Technol. 2012 Jul 15;51(2):67-72. doi: 10.1016/j.enzmictec.2012.05.005. Epub 2012 May 17. Enzyme Microb Technol. 2012. PMID: 22664189 Review.

10

Dengue: a growing threat requiring vaccine development for disease prevention.

Bos S, Gadea G, Despres P. Bos S, et al. Pathog Glob Health. 2018 Sep;112(6):294-305. doi: 10.1080/20477724.2018.1514136. Epub 2018 Sep 14. Pathog Glob Health. 2018. PMID: 30213255 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

21 results

Results by year

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Related Articles by Review for PMID: 31369221

21 results

Results by year